Rosa Lapalombella, PhD

Professor
The Ohio State University
The Ohio State University Comprehensive Cancer Center

N/A

Poster(s):

• 1801 - Targeting BTKi-Resistant CLL Using the Dual Irreversible/Reversible 4th Generation BTK Inhibitor Rocbrutinib